If the CD8 T cells are activated efficiently, with addition of other traditional cancer therapy methods, such as monoclonal antibodies, chemotherapy, and radiation therapy, they all can work together synergistically to improve the efficiency of T cell-mediated tumor-killing effects [256,257,258,259,260]. The gene discussed is CD8A; the disease is cancer.